Showing results (2521-2530 of 2,892) with videos related to
Sort By:
Pageof 290
JCO Precision Oncology|June 29, 2018
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid TumorsAnshuman Panda, Anil Betigeri, Kalyanasundaram Subramanian, et al.The Annals of Thoracic Surgery|October 1, 2011
Effect of prior cardiac operations on survival after coronary artery bypass graftingDonald S Likosky, Stephen D Surgenor, Robert S Kramer, et al.The Annals of Thoracic Surgery|October 2, 2018
Intensity of Glycemic Control Affects Long-Term Survival After Coronary Artery Bypass Graft SurgeryMichael P Robich, Alexander Iribarne, Bruce J Leavitt, et al.Journal of Cardiac Surgery|June 19, 2019
A multi-center analysis of readmission after cardiac surgery: Experience of The Northern New England Cardiovascular Disease Study GroupSpencer W Trooboff, Patrick C Magnus, Cathy S Ross, et al.Viruses|April 30, 2021
Comparison of Serological Assays for the Detection of SARS-CoV-2 AntibodiesJoe James, Shelley Rhodes, Craig S Ross, et al.Emerging Microbes & Infections|April 30, 2024
A multi-species, multi-pathogen avian viral disease outbreak event: Investigating potential for virus transmission at the wild bird - poultry interfaceScott M Reid, Alexander M P Byrne, Fabian Z X Lean, et al.BMJ Open Diabetes Research & Care|May 21, 2026
Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulationStacey Sklepinski, Alexandria A Ratzki-Leewing, Jeph Herrin, et al.Journal of Hospital Medicine|July 8, 2015
Development and Validation of an Algorithm to Identify Planned Readmissions From Claims DataLeora I Horwitz, Jacqueline N Grady, Dorothy B Cohen, et al.JAMA Oncology|July 17, 2015
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted TherapiesJeffrey S Ross, Kai Wang, Laurie Gay, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancerKenneth R Hess, Keith Anderson, W Fraser Symmans, et al.Pageof 290